The Use of Quinolones for the Treatment of Shigellosis in Travelers
Shigellosis remains a major public health problem wherever sanitary conditions are poor. In developed countries, Shigella infections are most common in institutions for the mentally retarded, in day care centers, and among the poor. Examples of the latter are persons living in the inner cities or the Indian reservations of the United States where the incidence of shigellosis is much higher than for the general population .
KeywordsNalidixic Acid Antimicrob Agent Minimum Inhibitory Concen Toxic Megacolon Indian Reservation
Unable to display preview. Download preview PDF.
- 3.Bennish ML, Salam MA, Haider R, Barza M (1990) Therapy for shigellosis: II. Randomized double-blind comparison of ciprofloxacin and ampicillin. J Infect Dis 162: 7112–7116Google Scholar
- 4.Bennish ML, Azard AK,Yousefzadeh D (1991) Intestinal obstruction during shigellosis: incidence, clinical features, risk factors, and outcome. Gastroen-terology 101: 626–634Google Scholar
- 5.Centers for Disease Control (1986) Multiply resistant shigellosis in a daycare center, Texas. MMWR 35: 753–755Google Scholar
- 6.Centers for Disease Control (1987) Nationwide dissemination of multiply resistant Shigella sonnei following a common-source outbreak. MMWR 36: 633–634Google Scholar
- 7.Centers for Disease Control (1991) Shigella dysenteriae type 1 - Guatemala, 1991. MMWR 40: 421–428Google Scholar
- 10.Gotuzzo E, Oberhelman RA, Maguiña C, Berry SJ,Yi A, Guzman M, Ruiz R, Leon-Barua R, Sack RB (1989) Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults. Antimicrob Agents Chemother 33: 1101–1104Google Scholar
- 11.Keusch GT, Bennish ML (1991) Shigellosis. In: Evans AS, Brachman PS (eds) Bacterial infections of humans. Epidemiology and control. Plenum Press, New York, pp 593–620Google Scholar
- 12.Khan WA, Salam MA, Khan AM, Bennish ML (1991) Randomized, double-blinded comparison of short course ciprofloxacin with standard five day therapy in the treatment of severe shigellosis. In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago. American Society for MicrobiologyGoogle Scholar
- 13.Koster F, Levin J, Walker L,Tunk KSK, Gilman RH, Rahaman MM, Majid MA, Islam S, Williams RC (1978) Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med 298: 927–933Google Scholar
- 14.Parsonnet J, Greene KD, Gerber AR, Tauxe RV, Aguilar OCJ, Blake PA (1989) Shigella dysenteriae type 1 infections in US travellers to Mexico, 1988. Lancet 2: 543–546Google Scholar
- 16.Ronsmans C, Bennish ML,WierzbaT (1988) Diagnosis and management of dysentery by community health workers. Lancet 2: 552–555Google Scholar
- 17.Salam MA, Bennish ML (1988) Therapy for shigellosis: 1. Randomized, double-blind trial of nalidixic acid in childhood shigellosis. J Pediatr 113: 901–907Google Scholar